Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-23T01:30:14.587Z Has data issue: false hasContentIssue false
  • English
  • Français

Incidence and outcomes of prosthetic valve endocarditis in adults with tetralogy of Fallot

Published online by Cambridge University Press:  08 January 2020

Alexander C. Egbe Open the ORCID record for Alexander C. Egbe [Opens in a new window] ,
Srikanth Kothapalli ,
William R. Miranda ,
Raja Jadav ,
Keerthana Banala ,
Rahul Vojjini ,
Faizan Faizee ,
Fouad Khalil ,
Maria Najam  and
Mounika Angirekula
...Show all authors
Alexander C. Egbe*
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Srikanth Kothapalli
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
William R. Miranda
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Raja Jadav
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Keerthana Banala
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Rahul Vojjini
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Faizan Faizee
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Fouad Khalil
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Maria Najam
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Mounika Angirekula
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Daniel C. Desimone
Affiliation:
Department of Internal Medicine, Mayo Clinic Rochester, Rochester, MN, USA
Heidi M. Connolly
Affiliation:
Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, MN, USA
*
Author for correspondence: A. C. Egbe, MD, MPH, FACC, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 284 2520; Fax: +1 507 266 0103; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The risk of endocarditis varies with CHD complexity and the presence of prosthetic valves. The purpose of the study was therefore to describe incidence and outcomes of prosthetic valve endocarditis in adults with repair tetralogy of Fallot.

Methods:

Retrospective review of adult tetralogy of Fallot patients who underwent prosthetic valve implantation, 1990–2017. We defined prosthetic valve endocarditis-related complications as prosthetic valve dysfunction, perivalvular extension of infection such abscess/aneurysm/fistula, heart block, pulmonary/systemic embolic events, recurrent endocarditis, and death due to sepsis.

Results:

A total of 338 patients (age: 37 ± 15 years) received 352 prosthetic valves (pulmonary [n = 308, 88%], tricuspid [n = 13, 4%], mitral [n = 9, 3%], and aortic position [n = 22, 6%]). The annual incidence of prosthetic valve endocarditis was 0.4%. There were 12 prosthetic valve endocarditis-related complications in six patients, and these complications were prosthetic valve dysfunction (n = 4), systemic/pulmonary embolic events (n = 2), heart block (n = 1), aortic root abscess (n = 1), recurrent endocarditis (n = 2), and death due to sepsis (n = 1). Three (50%) patients required surgery at 2 days, 6 weeks, and 23 weeks from the time of prosthetic valve endocarditis diagnosis. Altogether three of the six (50%) patients died, and one of these deaths was due to sepsis.

Conclusions:

The incidence, complication rate, and outcomes of prosthetic valve endocarditis in tetralogy of Fallot patients underscore some of the risks of having a prosthetic valve. It is important to educate the patients on the need for early presentation if they develop systemic symptoms, have a high index of suspicion for prosthetic valve endocarditis, and adopt a multi-disciplinary care approach in this high-risk population.

Keywords

Tetralogy of Fallotinfective endocarditisprosthetic valve endocarditis
Type
Original Article
Information
Cardiology in the Young , Volume 30 , Issue 1 , January 2020 , pp. 19 - 23
Copyright
© Cambridge University Press 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sabate Rotes, A, Bonnichsen, CR, Reece, CL, et al.Long-term follow-up in repaired tetralogy of Fallot: can deformation imaging help identify optimal timing of pulmonary valve replacement? J Am Soc Echocardiogr 2014; 27: 1305–1310.CrossRefGoogle ScholarPubMed
Nollert, G, Fischlein, T, Bouterwek, S, Bohmer, C, Klinner, W, Reichart, B.Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997; 30: 1374–1383.CrossRefGoogle ScholarPubMed
Oosterhof, T, van Straten, A, Vliegen, HW, et al.Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116: 545–551.CrossRefGoogle ScholarPubMed
Jones, TK, Rome, JJ, Armstrong, AK, et al.Transcatheter pulmonary valve replacement reduces tricuspid regurgitation in patients with right ventricular volume/pressure overload. J Am Coll Cardiol 2016; 68: 1525–1535.CrossRefGoogle ScholarPubMed
Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57–e185.CrossRefGoogle Scholar
Baumgartner, H, Falk, V, Bax, JJ, et al.2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739–2791.CrossRefGoogle ScholarPubMed
Wilson, W, Taubert, KA, Gewitz, M, et al.Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–1754.CrossRefGoogle Scholar
Habib, G, Lancellotti, P, Antunes, MJ, et al.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075–3128.CrossRefGoogle Scholar
Tutarel, O, Alonso-Gonzalez, R, Montanaro, C, et al.Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 2018; 104: 161–165.CrossRefGoogle ScholarPubMed
Kuijpers, JM, Koolbergen, DR, Groenink, M, et al.Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 2017; 38: 2048–2056.Google ScholarPubMed
Li, JS, Sexton, DJ, Mick, N, et al.Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633–638.CrossRefGoogle Scholar
Zoghbi, WA, Adams, D, Bonow, RO, et al.Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30: 303–371.CrossRefGoogle ScholarPubMed
Berglund, E, Johansson, B, Dellborg, M, et al.High incidence of infective endocarditis in adults with congenital ventricular septal defect. Heart 2016; 102: 1835–1839.CrossRefGoogle ScholarPubMed
Glaser, N, Jackson, V, Holzmann, MJ, Franco-Cereceda, A, Sartipy, U.Prosthetic valve endocarditis after surgical aortic valve replacement. Circulation 2017; 136: 329–331.CrossRefGoogle ScholarPubMed
Hubert, S, Thuny, F, Resseguier, N, et al.Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol 2013; 62: 1384–1392.CrossRefGoogle Scholar
Anguera, I, Miro, JM, Evangelista, A, et al.Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol 2006; 98: 1254–1260.CrossRefGoogle ScholarPubMed
Chan, KL.Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ 2002; 167: 19–24.Google ScholarPubMed
Graupner, C, Vilacosta, I, SanRoman, J, et al.Periannular extension of infective endocarditis. J Am Cardiol 2002; 39: 1204–1211.CrossRefGoogle ScholarPubMed
Miranda, WR, Connolly, HM, Bonnichsen, CR, et al.Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. Eur Heart J Card Img 2016; 17: 936–943.CrossRefGoogle ScholarPubMed
Malekzadeh-Milani, S, Ladouceur, M, Iserin, L, Bonnet, D, Boudjemline, Y.Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation. J Thorac Cardiovasc Surg 2014; 148: 2253–2259.CrossRefGoogle ScholarPubMed
Thuny, F, Grisoli, D, Collart, F, Habib, G, Raoult, D.Management of infective endocarditis: challenges and perspectives. Lancet 2012; 379: 965–975.CrossRefGoogle Scholar